Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-072734
Filing Date
2020-06-12
Accepted
2020-06-12 11:44:42
Documents
2
Period of Report
2020-06-11

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3878
2 EX-24 ex-24.htm EX-24 8560
  Complete submission text file 0001104659-20-072734.txt   13883
Mailing Address DYAX CORP. 55 NETWORK DRIVE BURLINGTON MA 01803
Business Address
ADELMAN BURT A (Reporting) CIK: 0001226283 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 20959453

Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations